Adjuvanted intranasal vaccine shows promise for long-lasting immunity to COVID-19

While much of the global concern has subsided, COVID-19 is still a very real threat, especially to people with compromised immune systems or who are over 65.

Curaleaf Q2 Revenue Lifts 1% Sequentially

Curaleaf Reports Second Quarter 2023 Results Second quarter 2023 revenue of $339 million, representing an increase of 4% year-over-year, and adjusted EBITDA¹ of $70 million

August 10, 2023

Psilocybin May Be More Cost-Effective than Current Treatments for Depression, Major New Study Finds | Psychedelic Spotlight

Psilocybin-based treatment combined with therapy may provide more cost-effective solution to treating Major Depressive Disorder than methods such as CBT It was also found to

July 6, 2023

Catheter ablation linked to lower risk of dementia in all patients with atrial fibrillation

Previous studies have shown a link between catheter ablation and a lower risk of dementia and premature death for patients with atrial fibrillation.

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.